4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-002289
Chief Medical Officer sold 14,502 shares at an average $19.55 ($283,506)
- Chief Medical Officer acquired 11,725 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-01-02 | Sale | −4,875 | $19.43 | $94,721 | 143,515 | I |
| Ho Carole Chief Medical Officer | 2019-01-02 | Sale | −900 | $20.24 | $18,216 | 142,615 | I |
| Ho Carole Chief Medical Officer | 2019-01-03 | Option exercise | +5,775 | $5.28 | $30,492 | 8,552 | D |
| Ho Carole Chief Medical Officer | 2019-01-03 | Sale | −2,777 | $18.90 | $52,485 | 2,777 | D |
| Ho Carole Chief Medical Officer | 2019-01-04 | Option exercise | +5,950 | $5.28 | $31,416 | 8,727 | D |
| Ho Carole Chief Medical Officer | 2019-01-04 | Sale | −1,500 | $19.30 | $28,950 | 7,227 | D |
| Ho Carole Chief Medical Officer | 2019-01-04 | Sale | −4,450 | $20.03 | $89,134 | 2,777 | D |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-01-03 | Option exercise · Stock Option (right to buy) | −5,775 | 108,335 | D | ||
| Ho Carole Chief Medical Officer | 2019-01-04 | Option exercise · Stock Option (right to buy) | −5,950 | 102,385 | D | ||
| Open-market sales · 14,502 sh · avg $19.55 · $283,506 | |||||||
Loading xslF345X03/doc4.xml…